TR2
(Plasmid
#218403)
-
PurposeExpresses TR2 peptide in AAV9 capsid
-
Depositing Lab
-
Sequence Information
Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | |
|---|---|---|---|---|---|
| Plasmid | 218403 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 | |
This material is available to academics and nonprofits only.
Backbone
-
Vector backbonepAR9
-
Backbone manufacturerMGH
- Total vector size (bp) 7483
-
Vector typeAAV
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)NEB Stable
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert nameTR2 7mer (RTTASLM)
-
Insert Size (bp)21
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please visit https://doi.org/10.1101/2023.09.13.557506 for bioRxiv preprint.
How to cite this plasmid
( Back to top)
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
TR2 was a gift from Casey Maguire (Addgene plasmid # 218403 ; http://n2t.net/addgene:218403 ; RRID:Addgene_218403) -
For your References section:
In vivo selection in non-human primates identifies AAV capsids for on-target CSF delivery to spinal cord. Hanlon KS, Cheng M, Ferrer M, Ryu JR, Lee B, De La Cruz D, Patel N, Espinoza P, Santoscoy MC, Gong Y, Ng C, Nguyen DM, Nammour J, Clark SQ, Heine VM, Sun W, Kozarsky K, Maguire CA. Molecular Therapy. 2024 Jun 5. doi.org/10.1016/j.ymthe.2024.05.040 10.1016/j.ymthe.2024.05.040 PubMed 37745398
